Clinical Scorecard: Doctor convicted in 2 million–pill stimulant scheme
At a Glance
Category
Detail
Condition
ADHD treatment and stimulant prescribing in an alleged illegal distribution and health care fraud scheme
Key Mechanisms
The DOJ reported that stimulants were prescribed through an online ADHD platform without patient examinations, including to people with substance use disorders and psychiatric conditions reportedly worsened by stimulant treatment.
Target Population
Patients receiving stimulant prescriptions through the Done Global online ADHD treatment platform
Care Setting
Digital health and online prescribing; the case was prosecuted in federal court in the Western District of Michigan.
Key Highlights
A federal jury convicted Michigan physician Jonathan Decker of conspiring to distribute controlled substances and six counts of distribution.
The DOJ said Decker prescribed more than 2 million pills of Adderall and other stimulants and received more than $1 million.
According to prosecutors, prescriptions were issued without examining patients, including patients with substance use disorders and serious psychiatric conditions.
The DOJ reported that the broader conspiracy involved distribution of more than 37 million Adderall pills to subscribers across all 50 states.
Decker faces a maximum statutory penalty of 140 years in prison; no sentencing date had been scheduled.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
The DOJ reported cases in which stimulant treatment exacerbated psychiatric symptoms, including psychosis, and described prescribing to patients with substance use disorders and other psychiatric conditions.
Patient & Prescribing Data
Subscribers to Done Global's online ADHD treatment platform, including individuals with substance use disorders and serious psychiatric conditions, according to the DOJ.
The DOJ said Decker prescribed more than 2 million pills of Adderall and other stimulants without examining patients. Prosecutors reported that some providers continued prescribing despite warnings about psychiatric conditions reportedly worsened by stimulants.
